glp-1 compounded Diabetes advocacy group discourages use of drugs GLP-1R agonist 2 | GLP-1R
Description
The causes of obesity: an in-depth review
A product that costs $75 per month translates to $900 per year and $4,500 over five years
Kirkegrd, J., Mortensen, F
N Engl J Med 387 , 205216 (2022)
Funding Funding was provided by Novo Nordisk which manufactures semaglutide
